Atlas Trials

Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants

Clinical trial NCT00761605 · COMPLETED

Trial details

NCT number
NCT00761605
Sponsor
Janssen Korea, Ltd., Korea
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2008-04-01
Primary completion
2010-09-01
Enrollment
387

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.